Logo image of BHK

BLACKROCK CORE BOND TRUST (BHK) Stock Overview

USA - NYSE:BHK - US09249E1010

9.86 USD
-0.02 (-0.2%)
Last: 10/23/2025, 4:15:00 PM
Fundamental Rating

1

Taking everything into account, BHK scores 1 out of 10 in our fundamental rating. BHK was compared to 0 industry peers in the Unkown industry. BHK has a bad profitability rating. Also its financial health evaluation is rather negative. BHK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BHK was profitable.
In the past year BHK has reported a negative cash flow from operations.
BHK had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BHK reported negative operating cash flow in multiple years.
BHK Yearly Net Income VS EBIT VS OCF VS FCFBHK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA 3.99%
ROE 5.37%
ROIC 2.55%
ROA(3y)-4.22%
ROA(5y)-0.73%
ROE(3y)-7.87%
ROE(5y)-2.25%
ROIC(3y)2.7%
ROIC(5y)2.62%
BHK Yearly ROA, ROE, ROICBHK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Profit Margin of BHK has declined.
In the last couple of years the Operating Margin of BHK has declined.
BHK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 59.62%
PM (TTM) 75%
GM 59.62%
OM growth 3Y-10.86%
OM growth 5Y-3.94%
PM growth 3Y27.32%
PM growth 5Y-41.84%
GM growth 3Y-11.26%
GM growth 5Y-4.25%
BHK Yearly Profit, Operating, Gross MarginsBHK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for BHK remains at a similar level compared to 1 year ago.
The number of shares outstanding for BHK remains at a similar level compared to 5 years ago.
BHK has a worse debt/assets ratio than last year.
BHK Yearly Shares OutstandingBHK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BHK Yearly Total Debt VS Total AssetsBHK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

BHK has an Altman-Z score of 1.33. This is a bad value and indicates that BHK is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.32 indicates that BHK is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACCN/A
BHK Yearly LT Debt VS Equity VS FCFBHK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

BHK has a Current Ratio of 0.05. This is a bad value and indicates that BHK is not financially healthy enough and could expect problems in meeting its short term obligations.
BHK has a Quick Ratio of 0.05. This is a bad value and indicates that BHK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
BHK Yearly Current Assets VS Current LiabilitesBHK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.43% over the past year.
BHK shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -41.49% yearly.
BHK shows a decrease in Revenue. In the last year, the revenue decreased by -0.52%.
BHK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.34% yearly.
EPS 1Y (TTM)30.43%
EPS 3Y28.56%
EPS 5Y-41.49%
EPS Q2Q%716.67%
Revenue 1Y (TTM)-0.52%
Revenue growth 3Y4.09%
Revenue growth 5Y1.34%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHK Yearly Revenue VS EstimatesBHK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.43, BHK is valued correctly.
BHK is valuated rather cheaply when we compare the Price/Earnings ratio to 27.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.43
Fwd PE N/A
BHK Price Earnings VS Forward Price EarningsBHK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHK Per share dataBHK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.32%, BHK is a good candidate for dividend investing.
BHK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 8.32%

5.2 History

The dividend of BHK has a limited annual growth rate of 2.47%.
BHK has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BHK decreased in the last 3 years.
Dividend Growth(5Y)2.47%
Div Incr Years0
Div Non Decr Years2
BHK Yearly Dividends per shareBHK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

120.51% of the earnings are spent on dividend by BHK. This is not a sustainable payout ratio.
The Dividend Rate of BHK has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP120.51%
EPS Next 2YN/A
EPS Next 3YN/A
BHK Yearly Income VS Free CF VS DividendBHK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
BHK Dividend Payout.BHK Dividend Payout, showing the Payout Ratio.BHK Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK CORE BOND TRUST

NYSE:BHK (10/23/2025, 4:15:00 PM)

9.86

-0.02 (-0.2%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.05%
Inst Owner Change0.06%
Ins OwnersN/A
Ins Owner Change0%
Market Cap712.09M
Revenue(TTM)52.00M
Net Income(TTM)39.00M
Analysts45
Price TargetN/A
Short Float %0.16%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 8.32%
Yearly Dividend0.87
Dividend Growth(5Y)2.47%
DP120.51%
Div Incr Years0
Div Non Decr Years2
Ex-Date10-15 2025-10-15 (0.0746)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.43
Fwd PE N/A
P/S 13.69
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)0.6
EY6.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.72
BVpS10.05
TBVpS10.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.65
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 5.37%
ROCE 4.27%
ROIC 2.55%
ROICexc 2.55%
ROICexgc 2.55%
OM 59.62%
PM (TTM) 75%
GM 59.62%
FCFM N/A
ROA(3y)-4.22%
ROA(5y)-0.73%
ROE(3y)-7.87%
ROE(5y)-2.25%
ROIC(3y)2.7%
ROIC(5y)2.62%
ROICexc(3y)2.7%
ROICexc(5y)2.62%
ROICexgc(3y)2.72%
ROICexgc(5y)2.64%
ROCE(3y)5.48%
ROCE(5y)5.06%
ROICexgc growth 3Y2.4%
ROICexgc growth 5Y1.44%
ROICexc growth 3Y2.75%
ROICexc growth 5Y1.83%
OM growth 3Y-10.86%
OM growth 5Y-3.94%
PM growth 3Y27.32%
PM growth 5Y-41.84%
GM growth 3Y-11.26%
GM growth 5Y-4.25%
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.59
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 1.33
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3Y28.56%
EPS 5Y-41.49%
EPS Q2Q%716.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.52%
Revenue growth 3Y4.09%
Revenue growth 5Y1.34%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.12%
EBIT growth 3Y-7.22%
EBIT growth 5Y-2.65%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-126.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.72%
OCF growth 3YN/A
OCF growth 5YN/A